A Phase 2 Trial of Concurrent Chemotherapy and Proton Therapy for Stage III Non-Small Cell Lung Cancer: Results and Reflections Following Early Closure of a Single-Institution Study-Reference-Cited by-同舟云学术

A Phase 2 Trial of Concurrent Chemotherapy and Proton Therapy for Stage III Non-Small Cell Lung Cancer: Results and Reflections Following Early Closure of a Single-Institution Study

Published:2016-05 Issue:1 Volume:95 Page:517-522
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Hoppe Bradford S.,Henderson Randal,Pham Dat,Cury James D.,Bajwa Abubakr,Morris Christopher G.,D’Agostino Harry,Flampouri Stella,Huh Soon,Li Zuofeng,McCook Barry,Nichols Romaine C.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference24 articles.

1. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: Randomized phase III trial RTOG 9410;Curran;J Natl Cancer Inst,2011

2. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

3. Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003;Dinan;J Clin Oncol,2012

4. Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer;Brugger;J Clin Oncol,2011

5. Are the results of RTOG 0617 mysterious?;Cox;Int J Radiat Oncol Biol Phys,2012

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic radiotherapy vs whole brain radiation therapy in EGFR mutated NSCLC: Results & reflections from the prematurely closed phase III HYBRID trial;Radiotherapy and Oncology;2024-08

2. Locally advanced non-small cell lung cancer: current issues and recent trends;Reports of Practical Oncology and Radiotherapy;2023-06-26

3. Efficacy and safety of particle therapy for inoperable stage II-III non-small cell lung cancer: a systematic review and meta-analysis;Radiation Oncology;2023-05-22

4. High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy;Advances in Radiation Oncology;2023-03

5. Dose escalation in the treatment of NSCLC with proton radiotherapy;Onkologie;2022-09-29